Skip Navigation


European Heart Journal Advance Access originally published online on February 8, 2006
European Heart Journal 2006 27(7):861-866; doi:10.1093/eurheartj/ehi773
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow All Versions of this Article:
27/7/861    most recent
ehi773v1
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (24)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Koch, A.
Right arrow Articles by Singer, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Koch, A.
Right arrow Articles by Singer, H.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The European Society of Cardiology 2006. All rights reserved. For Permissions, please e-mail: journals.permissions@oxfordjournals.org

B-type natriuretic peptide in paediatric patients with congenital heart disease

Andreas Koch*, Stefan Zink and Helmut Singer

Paediatric Cardiology, Department of Paediatrics and Adolescent Medicine, University of Erlangen-Nürnberg, Loschgestr. 15, D-91054 Erlangen, Germany

Received 24 June 2005; revised 13 December 2005; accepted 19 January 2006; online publish-ahead-of-print 8 February 2006.

* Corresponding author. Tel: +49 9131 8533118; fax: +49 9131 8535987. E-mail address: andreas.koch{at}kinder.imed.uni-erlangen.de

Aims To examine the diagnostic value of B-type natriuretic peptide (BNP) plasma concentration in congenital heart disease.

Methods and results BNP was measured in 288 consecutive patients (mean age 6.0±6.4 years) with left-to-right shunt, left or right heart obstruction, tetralogy of Fallot, functionally univentricular heart, or impaired left ventricular function and compared with age- and gender-specific normal values, and to haemodynamic and echocardiographic data. BNP increased with decreasing left ventricular shortening fraction (r=–0.80; P<0.001). In patients with left-to-right shunt, BNP was increased (mean SDS +1.64; P<0.001) and positively correlated (P<0.001) to shunt volume (r=0.66), systolic right ventricular pressure (r=0.69), mean pressure of the pulmonary artery (r=0.66), and pulmonary resistance (r=0.59). There was no correlation between BNP and invasive pressure gradient or extent of ventricular hypertrophy in patients with left or right heart obstruction. In patients with tetralogy of Fallot, BNP was not significantly increased. Patients with functionally univentricular heart had elevated BNP plasma levels (mean SDS +1.39; P<0.001) without decrease after volume unloading by cavopulmonary connection.

Conclusion In children with congenital heart defects, plasma BNP correlates closely to ventricular function. BNP plasma levels do not reflect directly the extent of ventricular pressure or volume work, but mirror the impairment of the loaded ventricles. Normal BNP cannot exclude pathology, but reflects a compensated status of the heart.

Key Words: BNP • Congenital heart disease • Ventricular function • Volume • Pressure • Resistance


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
J. Thorac. Cardiovasc. Surg.Home page
E. Lechner, E. M. Schreier-Lechner, A. Hofer, R. Gitter, R. Mair, A. Biebl, and G. Tulzer
Aminoterminal brain-type natriuretic peptide levels correlate with heart failure in patients with bidirectional Glenn anastomosis and with morbidity after the Fontan operation.
J. Thorac. Cardiovasc. Surg., September 1, 2009; 138(3): 560 - 564.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
D. Robbers-Visser, L. Kapusta, L. van Osch-Gevers, J. L.M. Strengers, E. Boersma, Y. B. de Rijke, F. Boomsma, A. J.J.C. Bogers, and W. A. Helbing
Clinical outcome 5 to 18 years after the Fontan operation performed on children younger than 5 years
J. Thorac. Cardiovasc. Surg., July 1, 2009; 138(1): 89 - 95.
[Abstract] [Full Text] [PDF]


Home page
ChestHome page
A. Bernus, B. D. Wagner, F. Accurso, A. Doran, H. Kaess, and D. D. Ivy
Brain Natriuretic Peptide Levels in Managing Pediatric Patients With Pulmonary Arterial Hypertension
Chest, March 1, 2009; 135(3): 745 - 751.
[Abstract] [Full Text] [PDF]


Home page
Circ Heart FailHome page
D. T. Hsu and G. D. Pearson
Heart Failure in Children: Part I: History, Etiology, and Pathophysiology
Circ Heart Fail, January 1, 2009; 2(1): 63 - 70.
[Full Text] [PDF]


Home page
Eur J Heart FailHome page
J. Mangat, C. Carter, G. Riley, Y. Foo, and M. Burch
The clinical utility of brain natriuretic peptide in paediatric left ventricular failure
Eur J Heart Fail, January 1, 2009; 11(1): 48 - 52.
[Abstract] [Full Text] [PDF]


Home page
HeartHome page
J P Kaski, M T Tome-Esteban, S Mead-Regan, A Pantazis, J Marek, J E Deanfield, W J McKenna, and P M Elliott
B-type natriuretic peptide predicts disease severity in children with hypertrophic cardiomyopathy
Heart, October 1, 2008; 94(10): 1307 - 1311.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
A. M.E. Koch
Plasma Levels of Brain Natriuretic Peptide in Children With Left-To-Right Shunt Before and After Cardiac Surgery
Ann. Thorac. Surg., August 1, 2008; 86(2): 693 - 694.
[Full Text] [PDF]


Home page
PediatricsHome page
K. O. Maher, H. Reed, A. Cuadrado, J. Simsic, W. T. Mahle, M. DeGuzman, T. Leong, and S. Bandyopadhyay
B-Type Natriuretic Peptide in the Emergency Diagnosis of Critical Heart Disease in Children
Pediatrics, June 1, 2008; 121(6): e1484 - e1488.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
J.-H. Hsu, P. E. Oishi, R. L. Keller, O. Chikovani, T. R. Karl, A. Azakie, I. Adatia, and J. R. Fineman
Perioperative B-type natriuretic peptide levels predict outcome after bidirectional cavopulmonary anastomosis and total cavopulmonary connection.
J. Thorac. Cardiovasc. Surg., April 1, 2008; 135(4): 746 - 753.
[Abstract] [Full Text] [PDF]


Home page
Eur J Heart FailHome page
A. M.E. Koch, S. Zink, H. Singer, and S. Dittrich
B-type natriuretic peptide levels in patients with functionally univentricular hearts after total cavopulmonary connection
Eur J Heart Fail, January 1, 2008; 10(1): 60 - 62.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
O. Chikovani, J.-H. Hsu, R. Keller, T. R. Karl, A. Azakie, I. Adatia, P. Oishi, and J. R. Fineman
B-type natriuretic peptide levels predict outcomes for children on extracorporeal life support after cardiac surgery.
J. Thorac. Cardiovasc. Surg., November 1, 2007; 134(5): 1179 - 1187.
[Abstract] [Full Text] [PDF]


Home page
Arch. Dis. Child. Fetal Neonatal Ed.Home page
A. El-Khuffash and E. J Molloy
Are B-type natriuretic peptide (BNP) and N-terminal-pro-BNP useful in neonates?
Arch. Dis. Child. Fetal Neonatal Ed., July 1, 2007; 92(4): F320 - F324.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.